Argentina’s Bioinnovo has updated its partnership with Spanish firm Algenex for the use of a molecule developed by the latter The renewed partnership provides Bioinnovo with the international rights to use Algenex’s APCH (antigen presenting […] See more

Last Tuesday Nov. 26rd a corporate meeting of the R&D international teams of Dr Bata, BV Science, Vetanco and Bioinnovo was held in Vetanco-Buenos Aires Head Office. The situation of ongoing projects and actual obstacles […] See more

Bioinnovo, the technology-based public-private company formed by the National Institute of Agricultural Technology (INTA) and Vetanco SA, agree to renew their contract with Algenex for the use of the APCH molecule, the targeting protein of […] See more

On November 3, Jeffrey W. Hall presented our latest news on developments in mucosal immunity applied to swine health, at the Animal Health Researchers Conference (CRWAD) held in Chicago. His lecture “Immunization of the mucosa […] See more

Besides our operation in Saint Louis, USA, we are adding more production and logistic capacity in order to attend more and better our increasing demand. BV Science, the company founded by Dr. Bata Ltd. from Hungary […] See more

BV Science is proud to announce that Hungarian Innovation Society awarded an innovation grand prize diploma our Dysantic. This grand prize diploma is the recognition of the research and development work of Dr. Bata team in the last years, […] See more

Maria, who started last week to work for BV Science, the company based in St Louis formed by Dr Bata and Vetanco, shared meetings with our technical and commercial teams in order to get acquainted […] See more

Jeffrey W. Hall will be our Research and Development Director in the USA directly reporting to Dr. Sherry Layton, Global CSO and to the Vetanco Board of Directors. Jeff obtained a B.S. degree in Biology; […] See more